AngioDynamics, Inc. (ANGO)
10.39
-0.24
(-2.26%)
USD |
NASDAQ |
Jan 23, 14:10
AngioDynamics Cash from Investing (Quarterly): -1.621M for Nov. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| Perspective Therapeutics, Inc. | 13.99M |
| InfuSystem Holdings, Inc. | -0.252M |
| Xtant Medical Holdings, Inc. | 4.679M |
| VolitionRX Ltd. | 0.0012M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.661M |
| Cash from Financing (Quarterly) | -0.092M |
| Free Cash Flow | -15.26M |
| Free Cash Flow Per Share (Quarterly) | 0.0732 |
| Free Cash Flow to Equity (Quarterly) | 0.848M |
| Free Cash Flow to Firm (Quarterly) | 3.142M |
| Free Cash Flow Yield | -3.57% |